UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Total revenue	$ 554.7	$ 424.0
Total cost of revenue	276.0	231.7
Gross profit	278.7	192.3
Operating expenses:
Selling, general and administrative	131.8	121.2
Research and development	54.8	48.5
Other charges, net	3.0	6.2
Total operating expenses	189.6	175.9
Operating income	89.1	16.4
Interest and other income (expense), net	(3.8)	(2.9)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	85.3	13.5
Income tax provision	27.5	2.9
Consolidated net income	57.8	10.6
Net income (loss) attributable to noncontrolling interests in consolidated subsidiaries	1.1	0.1
Net income attributable to Bruker Corporation	$ 56.7	$ 10.5
Net income per common share attributable to Bruker Corporation shareholders:
Basic (in dollars per share)	$ 0.37	$ 0.07
Diluted (in dollars per share)	$ 0.37	$ 0.07
Weighted average common shares outstanding:
Basic (in shares)	151.8	154.2
Diluted (in shares)	153.2	155.4
Comprehensive income	$ 41.6	$ 12.1
Less: Comprehensive income (loss) attributable to noncontrolling interests	0.9	(0.1)
Less: Comprehensive income (loss) attributable to redeemable noncontrolling interest		(0.5)
Comprehensive income attributable to Bruker Corporation	40.7	12.7
Product
Total revenue	458.6	345.0
Total cost of revenue	220.9	180.5
Service
Total revenue	94.1	78.2
Total cost of revenue	54.8	51.1
Other
Total revenue	2.0	0.8
Total cost of revenue	$ 0.3	$ 0.1